Kim Kyungbin, Park Won Young, Kim Jee Yeon, Sol Mee Young, Shin Dong Hun, Park Do Youn, Lee Chang Hun, Lee Jeong Hee, Choi Kyung Un
Department of Pathology, Pusan National University Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Korean J Pathol. 2012 Dec;46(6):532-40. doi: 10.4132/KoreanJPathol.2012.46.6.532. Epub 2012 Dec 26.
Tumor hypoxia is associated with malignant progression and treatment resistance. Hypoxia-related factors, such as carbonic anhydrase IX (CA IX), glucose transporter-1 (GLUT-1), and vascular endothelial growth factor (VEGF) permit tumor cell adaptation to hypoxia. We attempted to elucidate the correlation of these markers with variable clinicopathological factors and overall prognosis.
Immunohistochemistry for CA IX, GLUT-1, and VEGF was performed on formalin-fixed, paraffin-embedded tissues from 125 cases of ovarian epithelial cancer (OEC).
CA IX expression was significantly associated with an endometrioid and mucinous histology, nuclear grade, tumor necrosis, and mitosis. GLUT-1 expression was associated with tumor necrosis and mitosis. VEGF expression was correlated only with disease recurrence. Expression of each marker was not significant in terms of overall survival in OECs; however, there was a significant correlation between poor overall survival rate and high coexpression of these markers.
The present study suggests that it is questionable whether CA IX, GLUT-1, or VEGF can be used alone as independent prognostic factors in OECs. Using at least two markers helps to predict patient outcomes in total OECs. Moreover, the inhibition of two target gene combinations might prove to be a novel anticancer therapy.
肿瘤缺氧与恶性进展和治疗耐药相关。缺氧相关因子,如碳酸酐酶IX(CA IX)、葡萄糖转运蛋白-1(GLUT-1)和血管内皮生长因子(VEGF)可使肿瘤细胞适应缺氧环境。我们试图阐明这些标志物与各种临床病理因素及总体预后之间的相关性。
对125例卵巢上皮癌(OEC)福尔马林固定、石蜡包埋组织进行CA IX、GLUT-1和VEGF的免疫组织化学检测。
CA IX表达与子宫内膜样和黏液性组织学类型、核分级、肿瘤坏死及有丝分裂显著相关。GLUT-1表达与肿瘤坏死及有丝分裂相关。VEGF表达仅与疾病复发相关。在OEC中,各标志物的表达与总体生存率无关;然而,总体生存率低与这些标志物的高共表达之间存在显著相关性。
本研究表明,CA IX、GLUT-1或VEGF单独作为OEC独立预后因素是否可行值得怀疑。使用至少两种标志物有助于预测OEC患者的总体预后。此外,抑制两种靶基因组合可能成为一种新型抗癌疗法。